|
Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Research and Development |
| 1. |
Optimer Pharmaceuticals
|
|
|
Develops late-stage anti-infective and preclinical antibiotics by carbohydrate technology.
|
| 2. |
Intrabiotics Pharmaceuticals, Inc.
|
|
|
Develops antibacterial and antifungal drugs, including protegrins and related antimicrobial peptides, for application in cystic fibrosis. Includes pipeline, publications, and investor information from Palo Alto, California. (Nasdaq: IBPI)
|
| 3. |
Gemac
|
|
|
Researching diagnostics and drug candidates for the treatment of amyotrophic lateral and multiple sclerosis, as well as autoimmune diseases, including anti-idiotypic antibodies. Includes overview of corporation in Cenon, France.
|
| 4. |
Nephros Therapeutics, Inc.
|
|
|
Specialist in the design, development, and marketing of human cell replacement therapy systems, targeting inflammatory disease. Includes directions to research labs at Ann Arbor, Michigan, and corporate offices in Lincoln, Rhode Island.
|
| 5. |
Cyano Biotech GmbH.
|
|
|
Identifies and characterises structural variants of polyketides and non-ribosomal cyclic heptapeptides from cyanobacteria, and optimises pharmacological activity using biocombinatorial techniques. Profile, collaborators and contacts in Germany.
|
|
|
Add to My Favorite
Refer it to Friend
Report Broken Link
